Open AccessFriuli Venezia Giulia
Author(s) -
Maria Caterina Cavallo,
Filippo Cipriani,
Simone Gerzeli,
Nadia Demarteau,
Alessia Marocco,
Francesco Bamfi
Publication year - 2008
Publication title -
farmeconomia/farmeconomia e percorsi terapeutici
Language(s) - English
Resource type - Journals
eISSN - 1721-6923
pISSN - 1721-6915
DOI - 10.7175/fe.v9i1s.1005
Subject(s) - cohort , medicine , vaccination , demography , cohort study , pediatrics , virology , sociology
In Friuli Venezia Giulia region 75,1% of women (aged 25-64) are screened regularly, meaning every 3 years. Considering regional tariffs and vaccine acquisition cost, the vaccination of 12-year-old girls with a 90% coverage could prevent 15 cases of cervicocarcinoma and 6 related deaths and thus results to be cost-effective (27.766 €/QALY). When the vaccination programme is extended to 16-year-old girls a further 14 cancer cases and 6 deaths could be prevented, with a very similar cost-effectiveness ratio. In Friuli Venezia Giulia region, the net cost for woman vaccinated is 167 € for the single cohort and 169 € for the multiple cohort